stigmasterol and Skin-Neoplasms

stigmasterol has been researched along with Skin-Neoplasms* in 3 studies

Other Studies

3 other study(ies) available for stigmasterol and Skin-Neoplasms

ArticleYear
Isolation and evaluation of anticancer efficacy of stigmasterol in a mouse model of DMBA-induced skin carcinoma.
    Drug design, development and therapy, 2015, Volume: 9

    Stigmasterol (99.9% pure) was isolated from Azadirachta indica and its chemopreventive effect on 7,12-dimethylbenz[a]anthracene (DMBA)-induced skin cancer was investigated in Swiss albino mice. Skin tumors were induced by topical application of DMBA and promoted by croton oil. To assess the chemopreventive potential of stigmasterol, it was orally administered at a concentration of 200 mg/kg and 400 mg/kg three times weekly for 16 weeks. Reduction in tumor size and cumulative number of papillomas were seen as a result of treatment with stigmasterol. The average latency period was significantly increased as compared with the carcinogen-treated control. Stigmasterol induced a significant decrease in the activity of serum enzymes, such as aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, and bilirubin as compared with the control. Stigmasterol significantly increased glutathione, superoxide dismutase, and catalase as compared with the control. Elevated levels of lipid peroxide and DNA damage in the control group were significantly inhibited by administration of stigmasterol. From the present study, it can be inferred that stigmasterol has chemopreventive activity in an experimental model of cancer. This chemopreventive activity may be linked to the oxidative stress of stigmasterol. The antigenotoxic properties of stigmasterol are also likely to contribute to its chemopreventive action.

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents, Phytogenic; Azadirachta; Croton Oil; Disease Models, Animal; DNA Damage; Dose-Response Relationship, Drug; Female; Male; Mice; Oxidative Stress; Skin Neoplasms; Stigmasterol

2015
Anticarcinogenicity potential of spinasterol isolated from squash flowers.
    Teratogenesis, carcinogenesis, and mutagenesis, 2000, Volume: 20, Issue:3

    Spinasterol, an antimutagen, was isolated from squash flowers by solvent partitioning and repeated vacuum liquid chromatography. Spinasterol was then tested for its anticarcinogenic potential by using the mouse skin tumor assay. There was a 90% skin tumor incidence for the positive control group (DMBA + croton oil + acetone). At a concentration of 15.0 microg/0.2 ml acetone, spinasterol decreased the incidence of skin tumors by 55.6% and decreased the number of tumors by 65.0% when applied immediately after croton oil. Hence, spinasterol showed antitumorigenic potential. It is not a co-carcinogen nor a co-tumor promoter as there was no increase in the incidence of skin tumors after spinasterol application. Teratogenesis Carcinog. Mutagen. 20:99-105, 2000.

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Carcinogens; Chloroform; Chromatography, Liquid; Cocarcinogenesis; Croton Oil; Cucurbitaceae; Drug Screening Assays, Antitumor; Methanol; Mice; Molecular Structure; Skin Neoplasms; Solvents; Stigmasterol; Time Factors

2000
[Observations on the changes of the serum protein picture in patients with cutaneous neoplasms undergoing treatment with Reichstein's substance F].
    Minerva dermatologica, 1959, Volume: 34

    Topics: Blood Proteins; Colchicine; Skin Neoplasms; Stigmasterol

1959